Who owns the HALDA THERAPEUTICS trademark?

The HALDA THERAPEUTICS trademark is owned by Halda Therapeutics OpCo, Inc..

What class is the HALDA THERAPEUTICS trademark registered in?

The HALDA THERAPEUTICS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for HALDA THERAPEUTICS?

The USPTO serial number for HALDA THERAPEUTICS is 88625022.

What is the registration number for HALDA THERAPEUTICS?

HALDA THERAPEUTICS is registered under USPTO registration number 6950371.

Sealvo

Home Search: HALDA THERAPEUTICSHALDA THERAPEUTICS #88625022

Back

Updated Oct 5, 2026·25 searches this week

View on USPTO TSDR Find similar marks

HAL

USPTO Trademark Record

REGISTERED

HALDA THERAPEUTICS

SN 88625022·Reg 6950371·Filed Sep 20, 2019

Owner Halda Therapeutics OpCo, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

HALDA THERAPEUTICS (Serial No. 88625022), Registration No. 6950371, is a registered US trademark filed on Sep 20, 2019 by Halda Therapeutics OpCo, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: January 10, 2029

Mark Intelligence

HALDA THERAPEUTICS (Reg. #6950371) is a registered US trademark that has been protecting its owner, Halda Therapeutics OpCo, Inc., since 2019. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 20, 2019

SERIAL

88625022

REG#

6950371

REGISTERED

Jan 10, 2023

Filing Information

StatusREGISTERED

Filing DateSep 20, 2019

Serial Number88625022

Registration No.6950371

Registration DateJan 10, 2023

Status DateJan 10, 2023

Published for OppositionMar 31, 2020

Filing Basis & Declarations

Standard Characters ClaimedUse Application Currently

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Nov 07, 2022

First use in commerce: Nov 07, 2022

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

53 events

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Apr 02, 2026

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Apr 02, 2026

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Apr 02, 2026

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Apr 02, 2026

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 02, 2026

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Apr 02, 2026

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

REGISTERED-PRINCIPAL REGISTER

Jan 10, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jan 10, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Dec 06, 2022

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Dec 05, 2022

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 23, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 22, 2022

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 5 GRANTED

Nov 22, 2022

SOU EXTENSION 5 GRANTED

STATEMENT OF USE PROCESSING COMPLETE

Nov 22, 2022

STATEMENT OF USE PROCESSING COMPLETE

SOU EXTENSION 5 FILED

Nov 10, 2022

SOU EXTENSION 5 FILED

SOU TEAS EXTENSION RECEIVED

Nov 10, 2022

SOU TEAS EXTENSION RECEIVED

TEAS STATEMENT OF USE RECEIVED

Nov 10, 2022

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Nov 10, 2022

USE AMENDMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 12, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

May 10, 2022

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 4 FILED

May 10, 2022

SOU EXTENSION 4 FILED

SOU EXTENSION 4 GRANTED

May 10, 2022

SOU EXTENSION 4 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 18, 2021

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Nov 16, 2021

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Nov 16, 2021

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

Nov 16, 2021

SOU EXTENSION 3 GRANTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Sep 20, 2021

TEAS CHANGE OF CORRESPONDENCE RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Sep 20, 2021

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Sep 20, 2021

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Sep 20, 2021

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 27, 2021

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

May 25, 2021

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

May 25, 2021

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

May 25, 2021

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 27, 2020

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Nov 25, 2020

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Nov 25, 2020

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Nov 25, 2020

SOU EXTENSION 1 GRANTED

ASSIGNED TO EXAMINER

Jul 23, 2020

ASSIGNED TO EXAMINER

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 26, 2020

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Mar 31, 2020

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 31, 2020

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 11, 2020

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 25, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 10, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 10, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 10, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Dec 22, 2019

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Dec 22, 2019

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 22, 2019

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Dec 20, 2019

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 30, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Sep 24, 2019

NEW APPLICATION ENTERED

Other Marks by Halda Therapeutics OpCo, Inc.

Additional USPTO filings from the same owner.

HAL

HALDA THERAPEUTICS

97330340

Halda Therapeutics OpCo, Inc.

REGISTERED

HAL

HALDA

88625096

Halda Therapeutics OpCo, Inc.

REGISTERED

RIP

RIPTAC

99107627

Halda Therapeutics OpCo, Inc.

PENDING

RIP

RIPTAC

97742256

Halda Therapeutics OpCo, Inc.

ABANDONED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

HAL

HALDA THERAPEUTICS

97330340

Halda Therapeutics OpCo, Inc.

REGISTERED

HAL

HALDA

88625096

Halda Therapeutics OpCo, Inc.

REGISTERED

AVE

AVELOS THERAPEUTICS

97439188

Avelos Therapeutics, Inc.

REGISTERED

VEL

VELVET THERAPEUTICS

98405135

Twister Biotech Inc.

REGISTERED

Other Marks by Danielle Rivera

Additional USPTO filings handled by the same attorney of record.

INT

INTUITION

85757693

REGISTERED

LET

LET IN THE LYTE

97388270

REGISTERED

LOG

LogoMark

87907753

REGISTERED

INL

INLEXZO

98531370

REGISTERED

HALDA THERAPEUTICS

Run a conflict check

Other Marks by Halda Therapeutics OpCo, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Danielle Rivera

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company